Subscribe To
Angion (angn) kidney drug misses third study goal in 2021
Angion's (ANGN) phase II study evaluating ANG-3777 in cardiac surgery-associated acute kidney injury fails ...
December 13, 2021, 1:50 pm
Angion (angn) kidney drug misses third study goal in 2021
Angion's (ANGN) phase II study evaluating ANG-3777 in cardiac surgery-associated acute kidney injury fails ...
December 13, 2021, 1:50 pm
Angion (angn) kidney drug misses third study goal in 2021
Angion's (ANGN) phase II study evaluating ANG-3777 in cardiac surgery-associated acute kidney injury fails ...
December 13, 2021, 1:50 pm
Valneva's covid-19 shot fails as booster in pfizer/biontech vaccinated population
Valneva SE (NASDAQ: VALN) has responded to data published from the U.K COV-Boost COVID-19 vaccine trial that investigated the reactogenicity and im...
December 3, 2021, 1:31 pm
Valneva's covid-19 shot fails as booster in pfizer/biontech vaccinated population
Valneva SE (NASDAQ: VALN) has responded to data published from the U.K COV-Boost COVID-19 vaccine trial that investigated the reactogenicity and im...
December 3, 2021, 1:31 pm
Valneva's covid-19 shot fails as booster in pfizer/biontech vaccinated population
Valneva SE (NASDAQ: VALN) has responded to data published from the U.K COV-Boost COVID-19 vaccine trial that investigated the reactogenicity and im...
December 3, 2021, 1:31 pm
Wood's ark fund fails to join broad market rally as lockdown stocks slip
The broad market relief rally on Monday left many so-called stay-at-home stocks behind, dealing another blow to Cathie Wood's ARK Innovation fund....
November 29, 2021, 1:15 pm
Wood's ark fund fails to join broad market rally as lockdown stocks slip
The broad market relief rally on Monday left many so-called stay-at-home stocks behind, dealing another blow to Cathie Wood's ARK Innovation fund....
November 29, 2021, 1:15 pm
Wood's ark fund fails to join broad market rally as lockdown stocks slip
The broad market relief rally on Monday left many so-called stay-at-home stocks behind, dealing another blow to Cathie Wood's ARK Innovation fund....
November 29, 2021, 1:15 pm
Activision ceo kotick would consider leaving if he can't quickly fix problems – wsj
The Chief Executive Officer of Activision Blizzard Inc Bobby Kotick has told senior managers at the company that he would consider stepping down if he...
November 21, 2021, 7:21 pm
Activision ceo kotick would consider leaving if he can't quickly fix problems – wsj
The Chief Executive Officer of Activision Blizzard Inc Bobby Kotick has told senior managers at the company that he would consider stepping down if he...
November 21, 2021, 7:21 pm
Activision ceo kotick would consider leaving if he can't quickly fix problems – wsj
The Chief Executive Officer of Activision Blizzard Inc Bobby Kotick has told senior managers at the company that he would consider stepping down if he...
November 21, 2021, 7:21 pm
Climate ngos to cite ahold to dutch regulator over reporting on plastics
Two environmental groups on Thursday will lodge a complaint against Ahold Delhaize to the Dutch market regulator, saying the supermarket group ...
November 18, 2021, 12:09 am
Climate ngos to cite ahold to dutch regulator over reporting on plastics
Two environmental groups on Thursday will lodge a complaint against Ahold Delhaize to the Dutch market regulator, saying the supermarket group ...
November 18, 2021, 12:09 am
Climate ngos to cite ahold to dutch regulator over reporting on plastics
Two environmental groups on Thursday will lodge a complaint against Ahold Delhaize to the Dutch market regulator, saying the supermarket group ...
November 18, 2021, 12:09 am
Bristol myers (bmy) uc candidate fails in phase ii study
Bristol Myers (BMY) suffers a setback as its phase II study of deucravacitinib for the treatment of moderate to severe ulcerative colitis ...
October 8, 2021, 10:20 am
Bristol myers (bmy) uc candidate fails in phase ii study
Bristol Myers (BMY) suffers a setback as its phase II study of deucravacitinib for the treatment of moderate to severe ulcerative colitis ...
October 8, 2021, 10:20 am
Bristol myers (bmy) uc candidate fails in phase ii study
Bristol Myers (BMY) suffers a setback as its phase II study of deucravacitinib for the treatment of moderate to severe ulcerative colitis ...
October 8, 2021, 10:20 am
Cousins properties' (cuz) heights union buyout fails to drive stock
The acquisition of Heights Union is in line with Cousins Properties' (CUZ) efforts to enhance its portfolio quality with trophy assets....
October 7, 2021, 8:10 pm
Cousins properties' (cuz) heights union buyout fails to drive stock
The acquisition of Heights Union is in line with Cousins Properties' (CUZ) efforts to enhance its portfolio quality with trophy assets....
October 7, 2021, 8:10 pm